市场调查报告书
商品编码
1535830
大麻二酚 (CBD) 宠物市场 - 按宠物类型、产品类型、应用、配销通路- 全球预测Cannabidiol (CBD) Pet Market - By Pet Type, Product Type, Application, Distribution Channel - Global Forecast 2024-2032 |
大麻二酚宠物市场规模从2024 年到2032 年的复合年增长率将达到18.2%,这主要是由于人们越来越关注产品供应的扩展,包括针对不同宠物需求量身定制的油、零食、胶囊和局部应用。例如,2022 年 5 月,波兰大麻公司 Kombinat Konopny 披露了利用大麻二酚 (CBD) 油为猫和狗生产宠物零食和相关产品的计划。最近,许多 CBD 产品都是针对特定条件而设计的,例如缓解焦虑、疼痛管理和关节支持。电子商务平台上 CBD 宠物产品的供应增加,使更广泛的受众更容易获得这些产品,也将推动市场成长。
CBD宠物产业分为宠物类型、产品类型、应用、配销通路、区域。
以宠物类型来看,由于潜在的健康益处,特别是在缓解疼痛、焦虑和整体健康方面,猫的产业价值预计将在 2024 年至 2032 年间出现利润丰厚的成长。除了刺激生病或正在接受化疗等治疗的猫的食慾外,CBD还支持整体健康,并可以改善生活质量,尤其是老年猫。油、零食和外用等各种产品形式的开发也将促进该细分市场的成长。
在应用方面,疼痛管理领域的大麻二酚宠物市场份额将在 2032 年大幅扩张。随着宠物主人越来越多地寻求传统药物的天然和整体替代品,CBD 已发展成为更安全、副作用更少的选择。
从地区来看,由于城市生活的开始和小型宠物的日益普及,亚太地区 CBD 宠物产业规模可能会在 2024 年至 2032 年间出现显着的复合年增长率。该地区越来越多的兽医认识到并支持在宠物中使用 CBD 产品,进一步增强了消费者的信心。宠物主人越来越意识到 CBD 对宠物的健康益处,例如缓解疼痛、减少焦虑和整体健康,这将影响产品需求。
Cannabidiol Pet Market size will record 18.2% CAGR from 2024-2032, led by the growing focus on the expansion of product offerings, including oils, treats, capsules, and topical applications tailored to different pet needs. For example, in May 2022, Polish hemp firm Kombinat Konopny disclosed plans to produce pet treats and related products for cats and dogs by using cannabidiol (CBD) oil. Of late, numerous CBD products are designed for specific conditions, such as anxiety relief, pain management, and joint support. Increased availability of CBD pet products on e-commerce platforms for making them more accessible to a wider audience will also anchor the market growth.
The CBD pet industry is classified into pet type, product type, application, distribution channel, and region.
By pet type, the industry value from the cats segment is anticipated to witness lucrative growth between 2024 and 2032, owing to the potential health benefits, particularly for pain relief, anxiety, and overall wellness. In addition to stimulating appetite in cats who are ill or undergoing treatments like chemotherapy, CBD supports general health and can improve the quality of life, especially in aging cats. The development of various product forms, such as oils, treats, and topicals will also boost the segment growth.
In terms of application, the cannabidiol pet market share from the pain management segment will depict significant expansion through 2032. CBD offers anti-inflammatory properties that help reduce inflammation-related pain, making it beneficial for conditions like arthritis and inflammatory diseases. With pet owners increasingly seeking natural and holistic alternatives to traditional pharmaceuticals, CBD has evolved as a safer option with fewer side effects.
Regionally, the Asia Pacific CBD pet industry size may accrue a noteworthy CAGR between 2024 and 2032, due to the onset of urban living and the growing popularity of smaller pets. More veterinarians across the region are recognizing and endorsing the use of CBD products for pets, further increasing consumer confidence. Growing awareness among pet owners about the health benefits of CBD for pets, such as pain relief, anxiety reduction, and overall wellness will influence the product demand.